Revance Therapeutics soars following IPO

|About: Revance Therapeutics, Inc. (RVNC)|By:, SA News Editor

After pricing its 6M-share IPO at $16, Revance Therapeutics (RVNC) opened at $21 and is now at $26.25, up 64%.

The developer of novel botox products currently has a market cap of $465M.

Prospectus, IPO preview